Caxton Associates (New York)’s Humana HUM Stock Holding History

Caxton Associates (New York)’s Portfolio HUM Stock Details HUM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-3,008	Closed	-$1.17M	–	611
2021 Q3	$1.17M	Buy	3,008 +2,057	+216%	+$873K	0.13%	82
2021 Q2	$421K	Sell	951 -582	-38%	-$254K	0.05%	216
2021 Q1	$643K	Buy	+1,533	New	+$612K	0.06%	122
2020 Q3	–	Sell	-748	Closed	-$290K	–	409
2020 Q2	$290K	Buy	+748	New	+$280K	0.03%	270
2019 Q4	–	Sell	-1,590	Closed	-$407K	–	462
2019 Q3	$407K	Buy	+1,590	New	+$446K	0.08%	175
2019 Q2	–	Sell	-3,077	Closed	-$818K	–	463
2019 Q1	$818K	Buy	3,077 +1,744	+131%	+$503K	0.12%	90
2018 Q4	$382K	Buy	+1,333	New	+$423K	0.06%	146
2017 Q4	–	Sell	-1,900	Closed	-$463K	–	423
2017 Q3	$463K	Buy	+1,900	New	+$466K	0.02%	360

Other funds holding HUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Caxton Associates (New York)'s HUM Position: Q4 2021 in Review

Caxton Associates (New York) sold out of Humana (HUM) in Q4 2021, closing a stake of 3,008 shares — an estimated $1.17M sold.

Caxton Associates (New York) first reported a position in HUM in Q3 2017 and held it in 8 quarters. The position peaked at $1.17M in Q3 2021. 927 funds tracked by Wall St. Rank hold HUM as of Q4 2021.

Caxton Associates (New York) reported no remaining Humana position as of Q4 2021 after selling out during the quarter.
Caxton Associates (New York) sold 3,008 Humana shares in Q4 2021, an estimated $1.17M.
Caxton Associates (New York) first reported a position in Humana in Q3 2017 and held it in 8 quarters.
Caxton Associates (New York)'s Humana position peaked at $1.17M in Q3 2021.
927 funds tracked by Wall St. Rank held Humana as of Q4 2021.

Based on Caxton Associates (New York)'s 13F filing for Q4 2021, filed 14 Feb 2022.